Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Sherri Chico"'
Autor:
Robert O. Dillman, Louis A. VanderMolen, Kanoe Allen, Neil M. Barth, Linda D. Beutel, Sherri Chico
Publikováno v:
American Journal of Clinical Oncology. 28:281-288
During 1990-1999, we treated 60 patients with breast cancer who had distant metastases with high-dose chemotherapy and autologous stem cell rescue (HDC) after they had responded to induction chemotherapy. HDC regimens were MiTepa (60 mg/m2 mitoxantro
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cee957b6e46c1100980f0fde9571ab29
https://doi.org/10.1097/01.coc.0000156917.43490.65
https://doi.org/10.1097/01.coc.0000156917.43490.65
Autor:
Sherri Chico, Robert O. Dillman
Publikováno v:
Journal of oncology practice. 1(3)
Purpose We sought to determine whether survival of patients managed at a large community hospital improved after an affiliated facility opened and its associated programs were initiated. Methods Survival data for patients with invasive cancer was obt
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5d2920151e221170ba796738f3206f13
https://pubmed.ncbi.nlm.nih.gov/20871689
https://pubmed.ncbi.nlm.nih.gov/20871689
Autor:
Carol DePriest, Sherri Chico, Patric M. Schiltz, Robin Anne Ellis, Linda D. Beutel, Christopher Duma, Robert O. Dillman, Kris Okamoto, Cristina de Leon
Publikováno v:
Journal of immunotherapy (Hagerstown, Md. : 1997). 27(5)
This study was performed to obtain safety and survival data for patients with histologically confirmed recurrent glioblastoma multiforme (GBM) who received intralesional lymphokine-activated killer (LAK) cells following surgery. LAK cells were genera
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::eab014da104e40737aa47b122495ffde
https://pubmed.ncbi.nlm.nih.gov/15314549
https://pubmed.ncbi.nlm.nih.gov/15314549
Publikováno v:
Journal of Clinical Oncology. 19:4350-4351
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a52d53e6b7073afedca601c41bfd4bc7
https://doi.org/10.1200/jco.2001.19.23.4350
https://doi.org/10.1200/jco.2001.19.23.4350
Autor:
Robert O. Dillman, Sherri Chico
Publikováno v:
Blood. 106:4650-4650
In a previous intramural study using tumor registry data, we found no difference in survival for all 222 patients diagnosed with low-grade (LG) or intermediate-grade (IG) non-Hodgkin’s lymphoma (NHL) during 1980–1989 compared to all 404 such pati
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::fcaca9367e9ba6f4a1593a2cc499d836
https://doi.org/10.1182/blood.v106.11.4650.4650
https://doi.org/10.1182/blood.v106.11.4650.4650